7. Corticobasal degeneration Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 16 / Drugs : 28 - (DrugBank : 13) / Drug target genes : 9 - Drug target pathways : 38
Corticobasal degeneration and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 7 | Corticobasal degeneration | - |
| 2 | Amyotrophic lateral sclerosis | 7.152 |
| 17 | Multiple system atrophy | 4.197 |
| 5 | Progressive supranuclear palsy | 4.185 |
| 6 | Parkinson disease | 4.064 |
| 74 | Prolactin secreting pituitary adenoma | 3.472 |
| 4 | Primary lateral sclerosis | 3.363 |
| 201 | Angelman syndrome | 3.283 |
| 164 | Oculocutaneous albinism | 3.105 |
| 140 | Dorabe syndrome | 3.009 |
| 90 | Retinitis pigmentosa | 3.005 |
| 299 | Cystic fibrosis | 2.894 |
| 309 | Progressive myoclonus epilepsy | 2.500 |
| 51 | Scleroderma | 1.856 |
| 20 | Adrenoleukodystrophy | 1.273 |
| 8 | Huntington disease | 1.071 |
| 86 | Pulmonary arterial hypertension | 1.060 |